Login  /  Register  | 3 premium articles left before you must register.

Pfizer vaccine hit by CDC delay

Published February 24. 2012 4:00AM   Updated February 24. 2012 7:06PM

Pfizer Inc.'s plans to market its pneumonia vaccine to older adults has received an icy reception from advisers for the U.S. Centers for Disease Control, who are waiting for more data before recommending that doctors administer the drug.

The CDC said Wednesday, just weeks after the U.S. Food and Drug Administration had OK'd the use of Prevnar 13 in adults 50 and over, that it will review data from a drug trial in Netherlands to be completed next year. Editor's note: This corrects an earlier version of this story, which identified the wrong country.

Pfizer said its marketing campaign will go forward. The delay isn't affecting its financial forecast for this year, Pfizer told Reuters news service.

News by Town

Most Recent Poll
What's your pick for the 2012 Oscar for best picture?
The Artist
13%
The Descendants
6%
Extremely Loud & Incredibly Close
5%
The Help
37%
Hugo
6%
Midnight in Paris
5%
Moneyball
11%
The Tree of Life
1%
War Horse
16%
Number of votes: 634

No current items found